Frontiers in Immunology (Dec 2018)

Galectin-Glycan Interactions as Regulators of B Cell Immunity

  • Nicholas Giovannone,
  • Nicholas Giovannone,
  • Logan K. Smith,
  • Bebhinn Treanor,
  • Bebhinn Treanor,
  • Charles J. Dimitroff,
  • Charles J. Dimitroff

DOI
https://doi.org/10.3389/fimmu.2018.02839
Journal volume & issue
Vol. 9

Abstract

Read online

Cell surface glycans and their glycan-binding partners (lectins) have generally been recognized as adhesive assemblies with neighbor cells or matrix scaffolds in organs and the blood stream. However, our understanding of the roles for glycan-lectin interactions in immunity has expanded substantially to include regulation of nearly every stage of an immune response, from pathogen sensing to immune contraction. In this Mini-Review, we discuss the role of the ß-galactoside-binding lectins known as galectins specifically in the regulation of B-lymphocyte (B cell) development, activation, and differentiation. In particular, we highlight several recent studies revealing new roles for galectin (Gal)-9 in the modulation of B cell receptor-mediated signaling and activation in mouse and man. The roles for cell surface glycosylation, especially I-branching of N-glycans synthesized by the glycosyltransferase GCNT2, in the regulation of Gal-9 binding activity are also detailed. Finally, we consider how dysregulation of these factors may contribute to aberrant immune activation and autoimmune disease.

Keywords